Abstract:NGS-based genetic testing in the diagnosis of rare diseases holds great promise to serve as a first-tier genetic testing tool in the near future.Advancement of NGS technologies provides many options for diagnosing rare disorders associated with different types of genetic variants. Factors must be balanced in a ‘fit-for-purpose’ implementation.The accuracy and reproducibility of NGS should be evaluated in a clinical setting to deliver reliable genetic testing results in different clinical stages of rare diseases.Artificial intelligence (AI) will play a central role in integrating diverse diagnosis information toward an enhanced diagnosis power for rare diseases. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation. Next-generation sequencing (NGS) technologies have changed the landscape of genetic testing in rare diseases. However, the rapid evolution of NGS technologies has outpaced its clinical adoption. Here, we re-evaluate the critical steps in the clinical application of NGS-based genetic testing from an informatics perspective. We suggest a ‘fit-for-purpose’ triage of current NGS technologies. We also point out potential shortcomings in the clinical management of genetic variants and offer ideas for potential improvement. We specifically emphasize the importance of ensuring the accuracy and reproducibility of NGS-based genetic testing in the context of rare disease diagnosis. We highlight the role of artificial intelligence (AI) in enhancing understanding and prioritization of variance in the clinical setting and propose deep learning frameworks for further investigation.

Big data and innovative bioinformatics approaches in personalized genomic medicine

State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response

Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges

Next-generation sequencing and bioinformatics in rare movement disorders

Bioinformatics and Computational Tools for Next-Generation Sequencing Analysis in Clinical Genetics

Bioinformatics in Psychiatric Genetics

Bioinformatic Challenges Detecting Genetic Variation in Precision Medicine Programs

Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?

Next-generation sequencing technologies: breaking the sound barrier of human genetics

The expanding diagnostic toolbox for rare genetic diseases

From DNA to Data: Transcending Beyond the Double Helix and Demystifying the Genetic Alchemy of Life Through NGS to Empower Precision Medicine

The use of next-generation sequencing in personalized medicine

Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics

Critical role of bioinformatics in translating huge amounts of next-generation sequencing data into personalized medicine

Interlacing Personal and Reference Genomes for Machine Learning Disease-Variant Detection

Precision Medicine Via the Integration of Phenotype-Genotype Information in Neonatal Genome Project

Hospital-wide access to genomic data advanced pediatric rare disease research and clinical outcomes

Computational Genomics in the Era of Precision Medicine: Applications to Variant Analysis and Gene Therapy

Whole genome sequencing in clinical practice

Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research

Biological data sciences in genome research